Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.

Norman C, Rollene NL, Erickson D, Miles JM, Bowers CY, Veldhuis JD.

Eur J Endocrinol. 2013 Nov 29;170(1):121-9. doi: 10.1530/EJE-13-0733. Print 2014 Jan.

PMID:
24114435
[PubMed - indexed for MEDLINE]
2.

Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.

Veldhuis JD, Evans WS, Bowers CY.

J Clin Endocrinol Metab. 2002 Feb;87(2):859-66.

PMID:
11836333
[PubMed - indexed for MEDLINE]
4.

Differential pulsatile secretagogue control of GH secretion in healthy men.

Norman C, Miles J, Bowers CY, Veldhuis JD.

Am J Physiol Regul Integr Comp Physiol. 2013 May 1;304(9):R712-9. doi: 10.1152/ajpregu.00069.2013. Epub 2013 Mar 13.

PMID:
23485864
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.

Shah N, Evans WS, Bowers CY, Veldhuis JD.

J Clin Endocrinol Metab. 2000 Aug;85(8):2649-59.

PMID:
10946861
[PubMed - indexed for MEDLINE]
6.

Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.

Hudson SB, Schroeder DR, Bailey JN, Mielke KL, Erickson D, Miles JM, Bowers CY, Veldhuis JD.

J Clin Endocrinol Metab. 2010 Jan;95(1):353-60. doi: 10.1210/jc.2009-1769. Epub 2009 Oct 26.

PMID:
19858315
[PubMed - indexed for MEDLINE]
Free PMC Article
7.
8.

Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.

Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD.

J Clin Endocrinol Metab. 2001 Feb;86(2):551-60.

PMID:
11158008
[PubMed - indexed for MEDLINE]
10.

Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.

Veldhuis JD, Bowers CY.

Am J Physiol Endocrinol Metab. 2009 May;296(5):E1085-92. doi: 10.1152/ajpendo.91001.2008. Epub 2009 Feb 24.

PMID:
19240251
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.

Shah N, Evans WS, Bowers CY, Veldhuis JD.

J Clin Endocrinol Metab. 1999 Jun;84(6):2140-50.

PMID:
10372723
[PubMed - indexed for MEDLINE]
12.

Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.

Veldhuis JD, Keenan DM, Bailey JN, Miles JM, Bowers CY.

Eur J Endocrinol. 2009 Aug;161(2):293-300. doi: 10.1530/EJE-09-0270. Epub 2009 May 20.

PMID:
19458139
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

E2 supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion.

Anderson SM, Wideman L, Patrie JT, Weltman A, Bowers CY, Veldhuis JD.

J Clin Endocrinol Metab. 2001 Dec;86(12):5904-11.

PMID:
11739462
[PubMed - indexed for MEDLINE]
14.

The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.

Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY.

J Clin Endocrinol Metab. 1997 Feb;82(2):590-9.

PMID:
9024260
[PubMed - indexed for MEDLINE]
15.

Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.

Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Gouwy S, Stockman W, Weekers F, Schetz M, Lauwers P, Bouillon R, Bowers CY.

Clin Endocrinol (Oxf). 1997 Nov;47(5):599-612.

PMID:
9425400
[PubMed - indexed for MEDLINE]
16.

Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.

Veldhuis JD, Norman C, Miles JM, Bowers CY.

J Clin Endocrinol Metab. 2012 Dec;97(12):4753-60. doi: 10.1210/jc.2012-2567. Epub 2012 Sep 18.

PMID:
22990092
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.

Bray MJ, Vick TM, Shah N, Anderson SM, Rice LW, Iranmanesh A, Evans WS, Veldhuis JD.

J Clin Endocrinol Metab. 2001 Jul;86(7):3143-9.

PMID:
11443179
[PubMed - indexed for MEDLINE]
18.

Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.

Erickson D, Keenan DM, Farhy L, Mielke K, Bowers CY, Veldhuis JD.

J Clin Endocrinol Metab. 2005 Mar;90(3):1741-51. Epub 2004 Dec 21.

PMID:
15613434
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.

Veldhuis JD, Keenan DM, Mielke K, Miles JM, Bowers CY.

Eur J Endocrinol. 2005 Oct;153(4):577-86.

PMID:
16189179
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk